Membrane vesicles (MVs) released from activated cells and blebs from apoptotic cells are increased in patients with vascular disease and in those with atherosclerotic lesions, and their contribution to inflammatory reactions has been suggested. At sites of inflammation, MVs could serve as rapidly available substrates for peroxidation, carry oxidized compounds to activate other cells, and amplify inflammation. Here, we show that MVs released from tert-butyl hydroperoxide-treated endothelial cells (ECs) and apoptotic blebs, but not MVs from Ca 2ϩ ionophore-treated ECs, stimulate monocyte adhesion to ECs, an important step in atherogenesis. We show that oxidized phospholipids, such as the previously identified 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC), are responsible for biological activity in MVs and apoptotic blebs. Natural antibodies from apolipoprotein E-null mice that recognize POVPC also recognize oxidized MVs, and pretreatment of MVs with these antibodies inhibits their ability to activate ECs. Furthermore, the biological activity of oxidized MVs is inhibited by platelet-activating factor receptor antagonists, which have been shown to inhibit the action of POVPC. Taken together, we show that oxidized MVs and apoptotic blebs stimulate ECs to specifically bind monocytes, with oxidized phospholipids (POVPC) being the active principle. In addition to oxidized lipoproteins, oxidized MVs and apoptotic blebs may play an important role in chronic inflammatory diseases, such as atherosclerosis. (Arterioscler Thromb Vasc Biol. 2002;22:101-107.) 
A ctivation of vascular cells or circulating blood cells by various agonists such as Ca 2ϩ ionophore, terminal complement proteins C5b-9, thrombin, lipopolysaccharide, tumor necrosis factor (TNF)-␣, or hydroperoxide [1] [2] [3] [4] [5] [6] causes the release of parts of the cell membrane (membrane vesicles [MVs] ), which is due to stimulation of different mechanisms, including increase in intracellular Ca 2ϩ and calpain activation. 5 In addition, cells undergoing apoptosis also shed parts of their membranes (apoptotic blebs), 7, 8 and this process has been shown to be accompanied by oxidative stress. 9 Modification of MVs is thought to render them biologically active, and there is increasing evidence that lipids in MVs can elicit cellular responses: it has been shown that after treatment with secretory phospholipase A 2 , platelet-derived MVs activate endothelial cells (ECs) and cause platelet aggregation, with arachidonic acid being the active principle 10, 11 ; MVs derived from platelets or red blood cells and treated with a combination of phospholipase A 2 and sphingomyelinase cause platelet aggregation, with lysophosphatidic acid being the active principle 2 ; and ECs exposed to peroxides release MVs that contain oxidized phospholipids and activated neutrophils. 4 These studies also indicate that modified MVs may play an important role in inflammation. 2, 4, [11] [12] [13] Indeed, levels of MVs were increased in patients with acute coronary syndrome, 14 diabetes mellitus, 15 and cardiopulmonary bypass, 16 in human atherosclerotic plaques, 17 and in pathological settings in which platelet activation was involved. 18 -20 Particularly, EC-derived MV levels were increased in the peripheral blood of patients with coagulation abnormality 3 and in patients with acute coronary syndrome. 14 In addition, apoptosis was shown to play an important role in various pathological settings, such as cardiomyopathy, acute myocardial infarction, myocarditis, and atherosclerosis (see reviews 8, 21 ) , and high levels of apoptotic blebs were detected in atherosclerotic plaques. 17 In the present study, we examined whether modified MVs and apoptotic blebs stimulate ECs to bind monocytes, an initiating event in atherogenesis. We demonstrate that apoptotic blebs and oxidatively modified, but not native, MVs contain proinflammatory oxidized phospholipids that elicit specific responses in ECs, leading to the adhesion of monocytes. Thus, oxidized MVs and apoptotic blebs may play an important role in atherogenesis and other chronic inflammatory diseases.
Methods

Materials
1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC), dimyristoylphosphatidylcholine, A23187 (Ca 2ϩ ionophore), E-Toxate (Limulus amoebocyte lysate), butylated hydroxytoluene (BHT), and polymyxin B were purchased from Sigma Chemical Co; tert-butyl hydroperoxide (t-BuOOH) was purchased from Aldrich. Platelet-activating factor (PAF) receptor antagonists Ginkolide B and rac-3-(N-octadecylcarbamoyl)-2-methoxy)-propyl-(2-thiazolioethyl)-phosphate (BN-52021 and CV-3988, respectively) were from BIOMOL. TNF-␣ was from Boehringer-Mannheim. Monoclonal anti-human mouse E-selectin IgG antibody was from R&D Systems; goat anti-mouse IgG was from Accurate Chemical & Scientific Corp; biotinylated goat anti-mouse IgM was from Accurate Chemical & Scientific Corp; monoclonal IgM against tissue plasminogen activator was from Technoclone; the ApoAlert annexin V apoptosis kit was from Clontech; and monoclonals E03, E06, and E014 (all IgMs) were from the La Jolla Specialized Center of Research core immunology laboratory.
Phospholipid Preparation
Oxidized PAPC (Ox-PAPC) and 1-palmitoyl-2-(5-oxovaleroyl)-snglycero-3-phosphorylcholine (POVPC) were prepared from PAPC as described previously. 22, 23 
Tissue Culture
Human umbilical vein ECs were prepared and cultured as described previously 24 and used for experiments at passages 2 to 5.
Isolation of MVs and Apoptotic Blebs
ECs were exposed to t-BuOOH (300 mol/L) in Hanks' balanced salt solution (2 hours, 37°C) or to Ca 2ϩ ionophore (10 mol/L) in modified Hanks' balanced salt solution containing 2.5 mmol/L CaCl 2 and 10 mmol/L HEPES (45 minutes, 37°C). 1, 4 Induction of apoptosis was performed by inhibition of anchorage-dependent cell spreading with the use of 1% BSA. 25 MVs and apoptotic bleb-containing culture supernatants were cleared from detached cells and debris (centrifugation at 500g, 10 minutes), pelleted by ultracentrifugation (100 000g, 90 minutes, 4°C), 1,3 washed, and resuspended in PBS containing 0.01% BHT. Viability was examined by using trypan blue (0.4%). Apoptosis was confirmed by cell morphology, DNA fragmentation, or annexin V staining. 26, 27 For oxidation in vitro, MVs derived from Ca 2ϩ ionophore-treated ECs were treated with t-BuOOH (30 mol/L) and Fe 2ϩ (5 mol/L) for 75 minutes at 37°C. BHT (0.01% final concentration) was added to all vesicle preparations. Protein content of MVs was determined by using Coomassie Reagent (Pierce). Lipid phosphorus content was measured as described. 28 Lipids isolated from 10 g of MV protein contained Ϸ0.1 g phosphorus. All preparations were examined for endotoxin content by Limulus amoebocyte lysate assay. Only preparations containing Ͻ50 pg/mL endotoxin were used. To further exclude the effects of endotoxin, in some experiments polymyxin B (50 g/mL) was added. 11
Microscopy
Membrane vesiculation was observed by light microscopy with the use of a Leitz Fluovert microscope at ϫ320 magnification. For electron microscopy, MV pellets were prefixed in 2.5% glutaraldehyde and 2% formaldehyde in sodium cacodylate buffer (0.1 mol/L) for 45 minutes, rinsed in sodium cacodylate buffer, postfixed in 0.75% osmium tetroxide for 30 minutes, rinsed in water, dehydrated with 2,2-dimethoxypropane (15 minutes), and embedded in Spurr's epoxy resin. Sections were made with a diamond knife on a Reichert Ultracut, mounted on dioxane Formvar (Merck)-coated copper grids, stained with uranyl acetate and lead citrate, and examined with a Zeiss EM 902.
Lipid Analysis
Total lipids were extracted according to Bligh and Dyer 29 and separated into neutral lipids, fatty acids, and polar lipids by thin-layer chromatography on silica gel 60W plates (Merck) with hexane/ diethyl ether/acetic acid (70:30:1). Lipids were visualized by iodine vapor and extracted by using methanol/chloroform/water (50: 25:20) .
Electrospray Ionization-Mass Spectrometry
Electrospray ionization-mass spectrometry was performed with a VG Quattro mass spectrometer (Micromass) connected to a PU-980 high-performance liquid chromatographic pump (0.1 mL/min, Jasco), an LG-980-02 Ternary Unit (Jasco), and a 10-port injection valve (VICI AG). Calibration was performed as described. 22 Cone voltage was operated at 65 V, and capillary voltage was operated at 4.5 kV in the positive mode. Phospholipids were dissolved in acetonitrile/water/formic acid (50:50:0.1) and introduced by flow injection (0.1 mL/min). 22 For quantification, dimyristoylphosphatidylcholine was used as an internal standard. 30, 31 Phospholipids were quantified on the basis of their ion intensity relative to the ion intensity of the internal standard. 30 -32 
Leukocyte Adhesion Assays
Adhesion of U-937 cells or HL-60 cells to ECs was performed as described previously. 33 U-937 and HL-60 used in the adhesion assays were shown to behave like human monocytes and neutrophils, respectively. 11, 33 Briefly, confluent ECs were incubated in 48-well plates with MVs or lipids resuspended in medium 199 containing 10% supplemented calf serum for 4 hours at 37°C. After washing of ECs, unstimulated U-937 or HL-60 cells (10 5 cells per well) were added to ECs for 15 minutes, and adherent cells were counted.
Cell ELISA
Confluent ECs in 96-well plates were treated for 4 hours at 37°C. The assay was then performed as described previously. 34 In all leukocyte adhesion assays and ELISA experiments, TNF-␣ (10 U/mL) was used as a positive control and yielded a reproducible 3-to 4-fold increase. Control indicates cells treated with medium only.
Flow Cytometry
MVs (0.25 g vesicle protein per microliter) were incubated with antibodies (25 g/mL in PBS, 1% BSA) for 30 minutes at 37°C. Primary antibody binding was detected with a biotinylated goat anti-mouse-IgM (1:500 dilution) followed by a streptavidin-Alexa Fluor 488 conjugate (1:500, Molecular Probes) with use of a Becton Dickinson fluorescence-activated cell sorter. To control for unspecific binding, the primary antibody was omitted in control experiments.
Statistical Analysis
One-way ANOVA and single regression were performed. Values of PϽ0.05 were considered statistically significant.
Results
Oxidized MVs and Apoptotic Blebs Stimulate Monocyte-Endothelial Interactions
Four different types of MVs and apoptotic blebs were used for stimulation of ECs: (1) MVs derived by treatment with t-BuOOH (t-BuMVs), (2) MVs derived by treatment with Ca 2ϩ ionophore (Ca 2ϩ -ionoMVs), (3) MVs derived by treatment with Ca 2ϩ ionophore and then oxidized in vitro (in vitro oxMVs), and (4) blebs derived from apoptotic ECs (apoptotic blebs).
Five to 10 minutes after treatment with t-BuOOH (300 mol/L), ECs started to release round-shaped MVs ( Figure  1A ). After 2 hours, 50% to 60% of ECs formed vesicles with a loss of viability of Ϸ10% (not shown). In accordance with previous reports, 35 no signs of apoptosis were detected (not shown).
Media obtained from stimulated ECs induced monocyte adhesion ( Figure 1B) , whereas media from untreated ECs were inactive (data not shown). Ultracentrifugation resulted in a significant loss of biological activity, indicating that biologically active MV had been released after treatment with t-BuOOH ( Figure 1B ). After ultracentrifugation, vesicle pellets were examined by electron microscopy, demonstrating large (up to 2.5 m in diameter), sealed, round-shaped MVs with an intact lipid bilayer ( Figure 1C ). Other structures seen may be vesicle fragments that were caused by rupture of MVs during workup.
Isolated t-BuMVs concentration-dependently induced monocyte adhesion (Figure 2A ). We hypothesized that t-BuMVs were oxidized and therefore biologically active. To test this hypothesis, ECs were treated with Ca 2ϩ ionophore, which causes vesiculation (similar to Figure 1A ), 5 presumably not involving oxidation. Viability was Ͼ92% after 2 hours, and ECs did not undergo apoptosis (data not shown). Ca 2ϩ -ionoMVs did not induce monocyte adhesion ( Figure  2B ). To prove the importance of oxidation of MVs to induce monocyte-EC interactions, Ca 2ϩ -ionoMVs were oxidized with t-BuOOH (30 mol/L) and iron (5 mol/L) in vitro. As hypothesized, in vitro oxMVs now stimulated monocyte binding ( Figure 2C ).
Polar Lipids Contained in Oxidized MVs Specifically Stimulate Monocyte-EC Interactions
Total lipid extracts from t-BuMVs and in vitro oxMVs, but not lipid extracts from Ca 2ϩ -ionoMVs, stimulated ECs to bind to monocytes ( Figure 3A) . Aqueous phases did not induce monocyte adhesion (data not shown). Only the phospholipid fraction of t-BuMVs and in vitro oxMVs induced monocyte adhesion to ECs, whereas fatty acids and neutral lipids were not active ( Figure 3B ). Neither fraction of Ca 2ϩ -ionoMVs was biologically active ( Figure 3B ).
Moreover, although total lipid extracts from in vitro oxMVs, but not those from Ca 2ϩ -ionoMVs, induced monocyte adhesion to ECs, neither of the 2 groups of MVs induced neutrophil adhesion or E-selectin expression on ECs (Table) . 
Determination of Active Component in Oxidized MVs and Apoptotic Blebs
Previous studies have shown that PAF receptor antagonists inhibited the action of Ox-PAPC on ECs. 36, 37 In this study, monocyte adhesion induced by oxidized MVs was significantly reduced by 2 PAF receptor antagonists, BN-52021 and CV-3988 (not shown). According to previously published data, 36 Using a single regression model, we found that levels of POVPC showed a fairly strong association (r 2 ϭ0.463, PϽ0.0001) and that lyso-PC showed a weak positive correlation (r 2 ϭ0.206, PϽ0.0103) with the extent of monocyte adhesion induced by MVs. Levels of PAPC (r 2 ϭ0.027, PϽ0.3802), PGPC (r 2 ϭ0.085, PϽ0.111), and PEIPC (r 2 ϭ0.179, PϽ0.177) were not correlated with biological activity.
These data suggest that POVPC might play a dominant role in mediating monocyte binding. Thus, we examined whether IgM monoclonal antibodies that bind to POVPC (E03 and E06) would recognize MVs. We show that E03 and E06 bind to oxidized MVs (Figure 4A and 4B) and much less to native MVs (not shown). Furthermore, the IgM monoclonal E014, which recognizes malondialdehyde-lysine epitopes, also binds strongly to the oxidized MVs ( Figure 4C ).
It has been shown that these antibodies bind to the surface of cells undergoing apoptosis and recognize apoptotic blebs, 39 indicating that apoptotic blebs also contain oxidized phospholipids. Indeed, apoptotic blebs derived from ECs induced monocyte binding ( Figure 5A ). The biological activity resided in the lipid fraction ( Figure 5B ).
Furthermore, we show that the ability of apoptotic blebs or MVs to induce monocyte adhesion was abolished by preincubation with E06 or E03 ( Figure 6A and 6B) . Similarly, E06 Values are percentage of control (meanϮSEM) and are representative of 3 separate experiments. Comparison of monocyte adhesion with neutrophil adhesion and E-selectin expression on ECs after stimulation with Ca 2ϩ -ionoMVs or in vitro oxMVs is shown. and E03 abolished the biological activity of lipid extracts of in vitro oxMVs ( Figure 6C ). In contrast, preincubation with E014, which was also strongly bound to oxidized MVs, had no effect, nor did an irrelevant IgM against tissue plasminogen activator ( Figure 6 ). Furthermore, E03 and E06 blocked monocyte adhesion induced by POVPC, whereas E014 and the irrelevant antibody had no effect ( Figure 6D ). No inhibitory effects of any antibody on TNF-␣-induced monocyte adhesion to ECs were observed (data not shown). Finally, E03, E06, E014, and the irrelevant antibody alone had no effect on monocyte adhesion (data not shown).
Oxidized MVs Specifically Induce Monocyte Adhesion to ECs
Discussion
It has been shown that levels of MVs and apoptotic blebs derived from various cell types were increased in patients with vascular disease. 3, 14, 15, [17] [18] [19] [20] Although a role for MVs in inflammatory processes has been implied, molecules responsible for the activation of vascular cells remain to be identified. In the present study, we demonstrate that oxidative modification of MVs led to the formation of lipid oxidation products that stimulated ECs to specifically bind monocytes, an important event in atherogenesis and other chronic inflammatory diseases. In contrast, MVs that were obtained by treatment of ECs with Ca 2ϩ ionophore did not show biological activity. In addition, membrane blebs derived from ECs that underwent apoptosis also contained these lipid oxidation products and were biologically active.
It is important to note that the process of membrane vesiculation can be distinguished from membrane blebbing during apoptosis. 5, 8, 35 It has been shown that incubation of ECs with high doses of t-BuOOH (up to 0.4 mmol/L) results in membrane vesiculation and loss of cell viability but fails to induce apoptosis. 35 In the present study, the treatment of ECs with t-BuOOH resulted in no significant loss of viability for up to 2 hours, and no signs of apoptosis were detected. However, we cannot exclude the possibility that some of the isolated vesicles after t-BuOOH treatment are indeed blebs from apoptotic cells.
Oxidation of PAPC results in the formation of biologically active oxidized phospholipids, which are present in minimally modified (MM)-LDL 22, 38, 40 and atherosclerotic lesions 22 and in mice fed a high-fat diet. 31, 41 PAF receptor antagonists inhibited the activities of Ox-PAPC in vitro 36 and in vivo. 37 In the present study, characterization of the active component of oxidized MVs and apoptotic blebs revealed that polar lipids in these vesicles were responsible for their biological activity. Quantitative analysis of the polar lipid fraction by electrospray ionization-mass spectrometry showed increased levels of the oxidized phospholipids POVPC, PEIPC, and PGPC 22, 38 in oxidized MVs compared with native MVs. Among these oxidized phospholipids, POVPC was shown to mimic the overall action of MM-LDL in terms of induction of leukocyte-endothelial interactions. 33, 42 Like MM-LDL, oxidized MVs stimulated ECs to specifically bind monocytes but not neutrophils. Furthermore, E-selectin, the major adhesion molecule involved in neutrophil adhesion to ECs, was not expressed on ECs treated with oxidized MVs. Thus, these effects show striking similarity to the biological effects of MM-LDL and Ox-PAPC on ECs and imply a role for POVPC.
There are several indications that in the present study, oxovaleroyl-containing phospholipids play a predominant role. First, regression analysis of the levels of POVPC in MVs with the capability of inducing monocyte-EC interactions showed a highly significant correlation. Second, autoantibodies from apoE-deficient mice, which specifically recognize POVPC, block the action of oxidized MVs. Third, 2 different PAF receptor antagonists, which were shown to inhibit the action of POVPC, 37 also blocked monocyte adhesion induced by oxidized MVs.
The importance of oxidized phospholipids is further underlined by the fact that in apoE-deficient mice, which spontaneously develop atherosclerosis, high titers of autoantibodies to various oxidation-specific epitopes of oxidized LDL have been found. 43 Some of these autoantibodies recognize specific epitopes, such as malondialdehyde-lysine (E014) or POVPC (E03 and E06). 44 It has been demonstrated that both the POVPC-binding autoantibodies (E03 and E06) and E014 bind to apoptotic blebs 39 as well as to oxidized MVs. Despite this, only E03 and E06 blocked the stimulation of ECs to bind monocytes by oxidized MVs. These results provide strong evidence for POVPC and other oxovaleroylcontaining phospholipids contributing to biological activity and suggest that natural E0 autoantibodies might play a role in modulating the effect of oxidized MVs and apoptotic blebs in vivo. Conceivably, these antibodies might provide a valuable therapeutical tool by blocking the stimulation of ECs induced by oxidized MVs.
We propose that at sites of inflammation, where increased oxidant stress occurs, oxidized MVs are potentially released from various cell types. Furthermore, MVs that were shown to circulate at basal levels in the peripheral blood 3 are potentially oxidized in the setting of systemic inflammation. Apoptotic blebs are generated at increased levels in various pathological conditions (see reviews 8, 21 ). Thus, in addition to oxidized lipoproteins, which are believed to play a crucial role in the development of the atherosclerotic lesion, oxidized MVs and apoptotic blebs represent novel sources for biologically active oxidized phospholipids. Therefore, oxidized MVs and apoptotic blebs may contribute to the initiation and progression of chronic inflammatory processes and the development of atherosclerotic lesions.
